Christoph Schmid

机构：Augsburg University, University of Augsburg, University Hospital Augsburg · ORCID：0000-0001-7070-487X

发表论文 363 篇 · 总被引 11976 次 · h-index 57

代表论文

• Outcomes of bispecific antibody therapy after CAR T-cell failure in relapsed/refractory large B-cell lymphoma (2025 · Blood Advances · 被引 36)
• Disease risk but not remission status determines transplant outcomes in AML: long-term outcomes of the ASAP trial (2025 · Blood · 被引 11)
• Prophylactic and pre-emptive donor lymphocyte infusion in patients with acute myeloid leukemia and myelodysplastic syndrome: validation of current recommendations and proposal of a modified outcome assessment (2025 · Haematologica · 被引 9)
• Young unrelated donors confer a survival advantage for patients with myeloid malignancies compared to older siblings (2025 · Leukemia · 被引 7)
• Current use of donor lymphocyte infusions after allogenic stem cell transplantation in Europe: a survey on behalf of the cellular therapy and immunobiology working party of the EBMT (2025 · Bone Marrow Transplantation · 被引 6)
• Pretransplant MRD does not seem to affect survival in NPM1 -mutated AML undergoing allogeneic stem cell transplantation (2025 · Blood Advances · 被引 6)